|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| 10-02 | Healthcare Stocks Fall Slightly -- Healthcare Roundup | DJ |
| 10-02 | Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | DJ |
Upcoming events on NOVARTIS
| 2026-10-27 | Earnings release - Q3 2026 | |
| 2027-02-02 | Earnings release - Annual 2026 |
Past events on NOVARTIS
| 2026-07-21 | Earnings release - Q2 2026 | |
| 2026-07-21 | Earnings presentation | 08:00 |
| 2026-04-28 | Earnings presentation | 08:00 |
| 2026-04-28 | Earnings release - Q1 2026 | |
| 2026-03-06 | Annual General Meeting | 04:00 |
| 2026-03-06 | Présentation aux Actionnaires / Analystes | 04:00 |
| 2026-02-04 | Earnings presentation | 08:00 |
| 2026-02-03 | Earnings release - Q4 2025 | |
| 2025-12-01 | Information meeting | 10:00 |
| 2025-11-20 | Présentation aux Actionnaires / Analystes | 03:00 |
| 2025-11-20 | Présentation aux Actionnaires / Analystes | 04:15 |
| 2025-10-30 | Information meeting | 11:30 |
| 2025-10-28 | Earnings presentation | 09:00 |
| 2025-10-27 | Earnings release - Q3 2025 |
Past dividends on NOVARTIS
| 2026-03-10 | Ex-dividend date - 3.7 CHF | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 46 660 46 810 -0.32% | 51 722 50 407 2.61% | 56 674 55 618 1.9% | 57 688 | 61 434 | 65 317 |
|
EBITDA Million USD | Released Forecast Spread | 17 937 18 223 -1.57% | 21 006 19 819 5.99% | 23 415 23 671 -1.08% | 23 316 | 25 295 | 27 258 |
|
EBIT Million USD | Released Forecast Spread | 16 372 16 735 -2.17% | 19 494 18 983 2.69% | 21 889 21 846 0.19% | 21 830 | 23 646 | 25 561 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9 123 10 323 -11.63% | 13 640 13 560 0.59% | 16 352 17 360 -5.81% | 16 289 | 18 461 | 20 387 |
|
Net income Million USD | Released Forecast Spread | 14 854 10 329 43.8% | 11 939 11 438 4.38% | 13 967 14 570 -4.14% | 14 228 | 15 791 | 17 630 |
|
EPS USD | Released Forecast Spread | 7,15 5,38 32.95% | 5,92 5,53 7% | 7,21 7,16 0.7% | 7,08 | 8,44 | 9,73 |
| Announcement Date | 31/01/24 | 31/01/25 | 04/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13 558 12 823 5.73% | 13 620 13 116 3.85% | 14 836 14 136 4.95% | 14 358 13 866 3.55% | 13 860 14 077 -1.54% | 13 524 13 480 0.33% | 14 951 14 057 6.36% | 28 475 26 951 5.66% | 14 645 | 14 976 | 14 289 | 15 599 | 15 760 | 16 031 |
|
EBITDA Million USD | Released Forecast Spread | 5 294 | 5 338 4 861 9.81% | 5 957 | 5 909 | 5 927 | 6 487 | 6 726 | 6 378 | ||||||
|
EBIT Million USD | Released Forecast Spread | 4 859 4 435 9.56% | 5 575 5 272 5.75% | 5 925 5 827 1.68% | 5 460 5 520 -1.08% | 4 929 5 010 -1.62% | 4 897 5 215 -6.1% | 5 940 5 332 11.4% | 10 837 10 246 5.77% | 5 637 | 5 474 | 5 466 | 6 322 | 5 855 | 5 560 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 285 3 478 -5.55% | 4 196 4 238 -0.99% | ||||||||||||
|
Net income Million USD | Released Forecast Spread | 2 820 2 585 9.08% | 3 606 3 255 10.78% | 4 024 3 909 2.93% | 3 930 3 652 7.61% | 2 404 2 414 -0.4% | 3 156 3 227 -2.21% | 3 257 3 314 -1.72% | 3 400 | 3 475 | |||||
|
EPS USD | Released Forecast Spread | 1,42 1,30 9.63% | 1,83 1,65 10.96% | 2,07 1,99 3.77% | 2,04 1,87 9.02% | 1,26 1,26 0.23% | 1,65 1,68 -2.07% | 1,71 1,73 -1.43% | 1,79 | 1,84 | |||||
| Announcement Date | 31/01/25 | 29/04/25 | 17/07/25 | 28/10/25 | 04/02/26 | 28/04/26 | 21/07/26 | 21/07/26 | - | - | - | - | - | - |
| 2026-10-08 |  | Ex-dividend date - 0.139 CNY | 00:00 |
| 2026-10-08 | | Sales and Revenue Release - Q3 2026 | 01:00 |
| 2026-10-09 | | Extraordinary General Meeting | 02:30 |
| 2026-10-12 | | Earnings presentation | 01:00 |
| 2026-10-13 | | Earnings release - Q3 2026 | 06:45 |
| 2026-10-13 | | Earnings presentation | 08:30 |
| 2026-10-13 | | Extraordinary General Meeting | 02:30 |
| 2026-10-13 | | Extraordinary General Meeting | |
| 2026-10-14 | | Extraordinary General Meeting | |
| 2026-10-14 | | Ex-dividend date - 1.02 CNY | 00:00 |
Past sector events for NOVARTIS
| 2026-10-02 | | Ex-dividend date - 0.63 USD | 00:00 |
| 2026-10-02 | | Analyst/Investor Day | 01:00 |
| 2026-10-01 | | Information meeting | 08:00 |
| 2026-10-01 | | Board of Directors Meeting | 05:30 |
| 2026-10-01 | | Ex-dividend date - 0.99186 INR | 00:00 |
| 2026-10-01 | | Ex-dividend date - 0.99186 INR | 00:00 |
| 2026-09-30 | | Information meeting | |
| 2026-09-30 | | Annual General Meeting | 01:30 |
| 2026-09-30 | | Présentation aux Actionnaires / Analystes | 01:30 |
| 2026-09-30 | | Extraordinary General Meeting | 02:30 |
- Stock Market
- Stocks
- NOVN Stock
- 0HKE Stock
- Calendar NOVARTIS
Select your edition
All financial news and data tailored to specific country editions
